This hypothesis stimulated our interest in determining if pro-inflammatory factors such as the ubiquitous kinase PKR, acting peripherally and in the brain, could contribute to abnormal molecular signals leading to increased neuroinflammation and AD brain lesions during systemic inflammation. This evidence concerns the gene EIF2AK2 and Alzheimer disease.